Organon International updates: news & description

Organon International News and Activities

Presence

Organon International develops and sells medicines and health products. Its main offerings include women’s health treatments, biosimilars, and established medicines for patients, healthcare providers, and health systems worldwide.

Organon International products and services overview:

Womens health
Established medicines
Biosimilar medicines
Prescription drugs

Revenue: ~$6 billion

Employees: 10,000

Headquarters: Jersey City, United States (USA)

Organon International is one of the...

Organon International is a company listed under the stock ticker OGN (US).

Organon International has a direct presence in 2 countries.

They are in:

Pharmaceuticals50%
Biotechnology50%

Acquisition, funding and merger involving Organon International.

Sun Pharma has announced the acquisition of Organon International (posted on January 22 2026).

Executives

View the org chart displaying its 44 main executives

Most searched biographies at Organon International

Popular executive movements at Organon International

Joseph Morrissey, who was Interim Chief Executive Officer, is promoted to Chief Executive Officer (posted on April 28 2026).
Grace Puma, who is Director will soon leave the company (posted on November 10 2025).
Irina Bolawa has joined the company as Head of Total Rewards, Europe (posted on November 5 2025).

Click here to view some more movements at Organon International

Create your alert
to follow the executive moves at Organon International.